St. Antonius Ziekenhuis — Clinical Trial Site

86 Registered trials

43 Currently recruiting

Organisation

St. Antonius Ziekenhuis

Location

Nieuwegein, Netherlands

Identifier

ORG-100023243

Address

Soestwetering 1, 3543 AZ, Netherlands

Departments

#1705:Cardiology
#8001: Pulmonology
02-038:Hematologie
1901: Lung diseases
801: Pulmonology - Oncology
Cardiology
Department of Nuclear Medicine
Department of Oncology
Department of Pulmonology
Department of Surgery
Dept Cardiology - Nieuwegein
Gastroenterology
Gastroenterology and Hepatology
Gynaecology
Hematologie
Hematology
HPB surgery
internal diseases
Internal Medicine
Internal Medicine/Oncology
Interne Geneeskunde
Interne geneeskunde, Medische Oncologie
Interventional Cardiology
Longziekten - St. Antonius Ziekenhuis / Lung Diseases St. Anthony Hospital
Loongziekten
Lung oncology
Medical oncology
medische oncologie
N/A
NA
Nephrology
Neurology
Oncologie
Oncology
Orthopedic surgery
Parent
Pediatrics
Pneumology
Pulmonary disease
Pulmonary diseases
Pulmonology
St. Antonius Ziekenhuis
Surgery
Urology

Clinical trials at this site (86)

Search interface

Study to evaluate the efficacy and safety of Durvalumab(MEDI4736) in combination with intravesical BCG for the treatment of patients diagnos… Ended

2023-505341-23-00 Non-muscle invasive bladder cancer 5 2018-07-27
Transplant BRaVE NHL: Phase I-II study combining Brentuximab Vedotin with second line salvage chemotherapy (R-DHAP) in CD30 positive diffuse… Ended

2023-510556-22-00 non-Hodgkin lymphoma (NHL) 4 2018-03-05
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lun… Ended

2023-505981-26-00 Non−Small Cell Lung Cancer 5 2015-11-20
An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) Ended

2023-508606-26-00 Metastatic castration-resistant prostate cancer (mCRPC) 5 2015-04-23
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Halted

2023-506194-35-00 Colorectal liver metastases 5 2024-11-21
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the tr… Ended

2023-506185-31-00 Idiopathic pulmonary fibrosis (IPF) 10 2024-07-18
Individualized anti-platelet therapy in patients with stable coronary artery disease undergoing stenting Ended

2023-504078-39-01 Stable coronary artery disease 6 2024-01-11
Routine versus selective protamine administration to reduce bleeding complications after transcatheter aortic valve implantation Ended

2023-504205-36-00 Aortic stenosis 11 2023-11-01
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD (ACTIVATE study) Ended

2022-501783-18-00 Parkinson’s Disease 4 2023-07-21
A study of efficacy and safety of various treatments in participants with idiopathic pulmonary fibrosis (IPF) Ended

2023-508729-28-00 Idiopathic pulmonary fibrosis 4 2023-04-25
A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous efzofitimod in patients wit… Ended

2023-506039-13-00 pulmonary sarcoidosis 5 2023-04-12
Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathi… Ended

2024-515964-30-00 Interstitial Lung Diseases (ILD), including but not lim 4 2021-07-14
Investigation to assess the effects of zalunfiban in patients with an acute heart attack Ended

2023-508485-15-00 Subjects with documented STEMI, presenting with persist 5 2021-04-22
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants wit… Ended

2023-508443-40-00 Lung Cancer, Non-Small Cell 5 2020-12-18